Related Experiment Video
Updated: Sep 13, 2025
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Comparative insights into mild cognitive impairment: A clinical case study with 18F-FDG and amyloid PET imaging
Shiv Patil1, Eric M Teichner, Robert C Subtirelu
1Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA. abass.alavi@uphs.upenn.edu.
Abstract:
Early detection of mild cognitive impairment (MCI) is crucial for initiating therapeutic interventions that may slow or prevent further cognitive deterioration. Mild cognitive impairment represents a transitional phase between normal cognitive aging and more severe forms of dementia, such as Alzheimer's disease (AD). Positron emission tomography (PET) can provide insight into the pathophysiology and progression of neurodegenerative processes associated with dementia and MCI using either fluorine-18 (18F)-florbetapir, which detects beta-amyloid plaque burden, or 18F-fluorodeoxyglucose (18F-FDG), which measures glucose metabolism. However, there are limited comparative studies using the two radiotracers to quantify cognitive decline. This case study presents an 83-year-old female with a clinical diagnosis of MCI and a mini-mental state examination (MMSE) score of 26, at the lower boundary for normal cognitive function; she was assessed with PET/computed tomography (CT) using both radiotracers. Although global assessments did not reveal significant abnormalities, localized findings showed hypometabolism in key brain regions, such as the posterior cingulate cortex, and beta-amyloid plaque accumulation in the anterior cingulate cortex. These results highlight the limitations of conventional cognitive assessments, like the MMSE, and underscore the potential value of PET imaging as a complementary diagnostic tool. The study supports the role of 18F-FDG as a stronger indicator of cognitive impairment due to its correlation with cognitive scores, while recognizing the need for further research to evaluate the predictive value of both PET tracers in early MCI detection and their potential to improve diagnostic accuracy.
Insights
Early detection of mild cognitive impairment (MCI) is vital. Positron emission tomography (PET) scans using 18F-FDG show promise in identifying cognitive decline and complementing traditional assessments.
Area of Science:
- Neuroscience
- Radiology
- Geriatrics
Background:
- Mild cognitive impairment (MCI) is a critical stage between normal aging and dementia, necessitating early detection for intervention.
- Positron emission tomography (PET) imaging with radiotracers like 18F-florbetapir (amyloid burden) and 18F-FDG (glucose metabolism) offers insights into neurodegeneration.
- Comparative studies of these PET tracers for quantifying cognitive decline are limited.
Purpose of the Study:
- To investigate the utility of dual-tracer PET imaging (18F-florbetapir and 18F-FDG) in a case of mild cognitive impairment (MCI).
- To compare the diagnostic value of amyloid PET and FDG-PET in assessing cognitive decline.
- To highlight the limitations of conventional cognitive tests and the complementary role of advanced imaging.
Main Methods:
- A case study of an 83-year-old female diagnosed with MCI (Mini-Mental State Examination score of 26).
- Assessment using PET/computed tomography (CT) with both 18F-florbetapir and 18F-FDG radiotracers.
- Analysis of global and localized brain findings, including hypometabolism and amyloid plaque deposition.
Main Results:
- Global PET assessments showed no significant abnormalities.
- Localized findings revealed hypometabolism in critical brain regions (e.g., posterior cingulate cortex) and amyloid plaque accumulation (e.g., anterior cingulate cortex).
- 18F-FDG PET demonstrated a stronger correlation with cognitive scores compared to amyloid PET.
Conclusions:
- Conventional cognitive assessments like the MMSE may have limitations in detecting early-stage cognitive impairment.
- PET imaging, particularly 18F-FDG, shows potential as a valuable complementary tool for diagnosing and monitoring MCI.
- Further research is needed to establish the predictive value of both PET tracers in early MCI detection and improve diagnostic accuracy.
More Related Videos
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
Related Concept Videos
01:29Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET